1. Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
   Tanya B. Dorff et al, 2022, Clinical Cancer Research CrossRef
2. PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy
   Xuefeng Zhang et al, 2017, Technology in Cancer Research & Treatment CrossRef
3. Variants in thePSCAgene associated with risk of cancer and nonneoplastic diseases: systematic research synopsis, meta-analysis and epidemiological evidence
   Huijie Cui et al, 2019, Carcinogenesis CrossRef
4. Contribution of prostate stem cell antigen variation rs2294008 to the risk of bladder cancer
   Shi Deng et al, 2019, Medicine CrossRef
5. PSCA gene expression in bladder, colorectal and prostate cancer patients from Basrah governorate southern of Iraq
   Anwar Noori Ayoob et al, 2024, Asia Pacific Journal of Molecular Biology and Biotechnology CrossRef
6. PSCArs2294008 T polymorphism increases the risk of bladder cancer in Bai, Dai, and Han ethnicity in China and a potential mechanism
   Junfeng Yang et al, 2018, Genes & Genomics CrossRef
7. Significance of PSCA as a novel prognostic marker and therapeutic target for cancer
   Tina Nayerpour Dizaj et al, 2024, Cancer Cell International CrossRef